CD8A and neoplasm: In C57BL/6 mice bearing B16-F10 tumors, THOR-707 showed increased intratumoral distribution and retention and stimulated a significant elevation in infiltrating CD8+ T and NK cells and dose-dependent reduction in tumor growth.